Circulation

Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial

By Marc P. Bonaca, Mario Enrico Canonico, Na Li, Stephen James Nicholls

Randomised trial in 13,970 peopleInterventions

Placebo-controlled, declared ties to: University of Colorado, Esperion Therapeutics, AstraZeneca and 49 more

The paper

Marc P. Bonaca, Mario Enrico Canonico, Na Li, Stephen James Nicholls

University of Colorado Anschutz; Monash University

Circulation, 18 Aug 2026

doi.org/10.1161/circulationaha.125.078469 PubMed 42610264

American Journal of Preventive Cardiology4 Oct 2026
Risk factors for atherosclerosis diverge across vascular beds
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
medRxiv4 Oct 2026
Social context predicts heart risks despite normal biomarkers
Journal of Diabetes and Metabolic Disorders4 Oct 2026
Cumulative non-HDL cholesterol is linked to CVD risk